Here, we provide the first evidence that activation of ERS promotes EMT in HCC cells via a key target gene of ERS-specific SE, CREB5, which is significantly upregulated in HCC tissues and is associated with poor prognosis and an aggressive phenotype. Here, CREB5 is linked to hepatocellular carcinoma.